Literature DB >> 11306964

T cytotoxic 1 and T cytotoxic 2 CD8 T cells both inhibit IgE responses.

M J Thomas1, P A MacAry, A Noble, P W Askenase, D M Kemeny.   

Abstract

BACKGROUND: It is well recognized that CD8 T cells inhibit IgE responses. In this study, we investigated the mechanism of CD8 T cell-mediated IgE suppression by comparing the capacity of T cytotoxic 1 (Tc1) and T cytotoxic 2 (Tc2) CD8 T cells to inhibit IgE responses to ovalbumin (OVA).
METHODS: Tc1 and Tc2 CD8 T cells were generated from OVA(257-264)-specific Vbeta5.2 T cell receptor (TcR) transgenic mice by stimulation with anti-CD3 and anti-CD28 under Tc1 and Tc2 polarizing conditions. Tc1 and Tc2 Vbeta5.2 TcR CD8 T cells (10(6)) were adoptively transferred to syngeneic mice, and following immunization with 100 micro of OVA/alum, serum IgE antibodies were measured by passive cutaneous anaphylaxis and expressed as the highest dilution that gave a detectable skin response.
RESULTS: Both Tc1 and Tc2 CD8 T cells from OT-I mice inhibited IgE.
CONCLUSION: Both Tc1 and Tc2 CD8 T cells promote Th1 immunity and inhibit IgE responses. This process appears to be independent of CD8 T cell-derived IFN-gamma, as both Tc2 (IFN-gamma-) and Tc1 (IFN-gamma+) CD8 T cells inhibited IgE. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306964     DOI: 10.1159/000053706

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  Allergen-specific CD8(+) T cells and atopic disease.

Authors:  Suranjith L Seneviratne; Louise Jones; Abigail S King; Antony Black; Sheila Powell; Andrew J McMichael; Graham S Ogg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 2.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

3.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

4.  Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors.

Authors:  Jayesh Kumar Tiwari; Shloka Negi; Manju Kashyap; Sheikh Nizamuddin; Amar Singh; Arun Khattri
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

5.  Th2 responses in OVA-sensitized BALB/c mice are down-modulated by Mycobacterium bovis BCG treatment.

Authors:  Ana Cláudia Carvalho Gouveia; Alessa Sin Singer Brugiolo; Caio César Souza Alves; Flávia Márcia Castro Silva; Felipe Pereira Mesquita; Jacy Gameiro; Ana Paula Ferreira
Journal:  J Clin Immunol       Date:  2012-08-04       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.